Drugs / Kanglaite Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01640730 | May → Oct 2012 | non-small cell lung carcinoma | KangLaiTe USA | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kanglaite Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01640730 ↗ |
| Route | Intravenous | “30gm IV infusion” NCT01640730 ↗ |